Transcriptomics

Dataset Information

0

Artemisinins target GABA receptor signaling to induce alpha to beta cell transdifferentiation


ABSTRACT: Type 1 diabetes is characterized by the destruction of pancreatic beta cells, and generating new insulin-producing cells from other cell types is a major aim of regenerative medicine. One promising approach is transdifferentiation of developmentally related pancreatic cell types including glucagon-producing alpha cells. In a genetic model, overexpression of the master regulatory transcription factor Pax4 or loss of its counterplayer Arx are sufficient to induce the conversion of alpha cells to functional beta-like cells. Here we identify artemisinins as small molecules that functionally repress Arx and induce beta-cell characteristics in alpha cells. We show that the protein gephyrin is the mammalian target of these antimalaria drugs. Finally, we demonstrate that gephyrin-mediated enhancement of GABAA receptor signaling is the mechanism of action of these molecules in pancreatic transdifferentiation. Our results indicate that gephyrin is a novel druggable target for the regeneration of pancreatic beta cell mass from alpha cells.

ORGANISM(S): Homo sapiens

PROVIDER: GSE84714 | GEO | 2017/01/19

SECONDARY ACCESSION(S): PRJNA330917

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2016-12-15 | GSE84592 | GEO
2017-02-16 | GSE79457 | GEO
| PRJNA922343 | ENA
| PRJNA330917 | ENA
2023-08-05 | GSE202206 | GEO
2023-08-05 | GSE203264 | GEO
| PRJNA316075 | ENA
2021-09-09 | GSE183568 | GEO
2022-01-29 | GSE178726 | GEO
2022-01-29 | GSE163947 | GEO